Dr. Gary A Green, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 670 Shepard Ln, Suite 102, Farmington, UT 84025 Phone: 801-451-7500 Fax: 801-451-6966 |
News Archive
AXT are proud to announce that they have just expanded their life science product portfolio with the addition of Fluicell's innovative tissue engineering systems. The new agreement will see AXT exclusively distribute their Biopixlar and BioPen product lines in Australia and New Zealand.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
Surgery for chronic low back pain is no better than intensive rehabilitation and is unlikely to be a cost-effective use of scarce healthcare resources, show two studies published online by the BMJ.
› Verified 6 days ago